References
- Nimer S D. Myelodysplastic syndromes. Blood 2008; 111: 4841–4851
- Steensma D P, Tefferi A. The myelodysplastic syndrome(s): a perspective and review highlighting current controversies. Leuk Res 2003; 27: 95–120
- McLaren G D, Carpenter J T, Jr, Nino H V. Erythrocyte protoporphyrin in the detection of iron deficiency. Clin Chem 1975; 21: 1121–1127
- Murphy P T, Quinn J P, O'Donghaile D, Swords R, O'Donnell J R. Myelodysplastic patients with raised percentage of hypohromic red cells have evidence of functional iron deficiency. Ann Hematol 2006; 85: 455–457
- Ross S D, Allen I E, Probst C A, Sercus B, Crean S M, Ranganathan G. Efficacy and safety of erythropoieis-stimulating proteins in myelodysplastic syndrome: a systematic review and meta-analysis. The Oncologist 2007; 12: 1264–1273
- Lutton J D, Abraham N G, Drummond G S, Levere R D, Kappas A. Zinc porphyrins: potent inhibitors of hematopoiesis in animal and human bone marrow. Proc Natl Acad Sci USA 1997; 94: 1432–1436